Advancing the Science of Hyperemesis Gravidarum: Our Research
Marlena Fejzo, PhD, and Dr. Andrew Housholder
Redefining HG Care Through Research
Our research pairs the discoveries of our Chief Scientific Officer, Marlena Fejzo, PhD, whose work helped link the hormone GDF15 to hyperemesis gravidarum, with the frontline experience of Andrew Housholder, MD, FACEP, a leading expert consulted by physicians worldwide on HG treatment.
More research
coming soon…